Experience

• • Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNA®), in its acquisition of ReNAgade Therapeutics
  • 3Play Media, Inc., a technology company that provides premium closed captioning, transcription, audio description and subtitling solutions in its acquisition by Riverside Partners
  • Affirmed Networks, a leader in wireless telecommunication equipments and solutions, in its sale to Microsoft Corporation
  • Aileron Therapeutics, a clinical stage chemoprotection oncology company, in its acquisition of Lung Therapeutics, a privately held biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications that have no approved or limited effective treatments
  • Akamai, the world’s most distributed cloud, security and content platform, in its acquisitions of Asavie Technologies, Exceeda, Guardicore, Janrain and Soha Systems
  • Alkermes, a global biopharmaceutical company developing innovative medicines in the field of neuroscience, in its acquisition of Rodin Therapeutics
  • Cloud9 Technologies LLC, a leader in integrated cloud-based communication solutions, in its acquisition by Symphony Communication Services Holdings
  • Disarm Therapeutics, a privately-held biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, in its sale to Eli Lilly
  • DriveWealth, a pioneer in fractional investing and embedded finance, in its acquisition of Crypto-Systems, LLC, a company that offers tailored market-making services to platforms for digital assets to provide deep and stable liquidity
  • Endurance International Group, an IT services company specializing in web hosting, in its acquisition by Clearlake Capital Group for $3 billion
  • GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells therapies for immunology, in its $157 million Series A financing
  • Gemini Therapeutics, a precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration, in its merger with Disc Medicine, Inc., a privately held, clinical-stage biopharmaceutical company
  • IMARA, a clinical-stage biopharmaceutical company, in its sale of assets to Cardurion Pharmaceuticals and its subsequent merger with Enliven Therapeutics
  • Lexicon Pharmaceuticals, a biopharmaceutical company developing treatments for human disease, in the sale of Xermelo to TerSera
  • MKS Instruments, a global provider of technologies that enable advanced processes and improve productivity, in its acquisition of Newport Corporation
  • Nasdaq Private Market, a leading provider of liquidity solutions to private companies, in its $62.4 million Series B Financing
  • Novo Nordisk, a leading global healthcare company, in its strategic collaboration with Flagship Pioneering to create a portfolio of transformational medicines
  • PerkinElmer, a global leader committed to innovating for a healthier world, in its $591 million acquisition of Oxford Immunotec, a global leader of proprietary test kits for latent tuberculosis
  • TMX Group, in its strategic investment in VettaFi, a US-based, privately owned data, analytics, indexing, digital distribution, and thought leadership company
  • Viamet Pharmaceuticals, a pharmaceutical company that develops small molecule inhibitors via an enzyme binding approach for the treatment of various diseases, in its sale to NovaQuest Capital Management
  • WEX, the global commerce platform that simplifies the business of running a business, in its acquisition of Electronic Funds Source
  • Zaius, a customer data platform bringing the context of the customer to the experience creation and optimization process of digital experiences, in its acquisition by Optimizely (formerly Episerver), a leading provider of digital experience platform solutions